Cargando…
Analysis of pregnancy outcomes following surgical treatment of cesarean scar pregnancy
PURPOSE: To investigate the surgical treatment approaches for patients with Cesarean scar pregnancy (CSP) and the effects on subsequent pregnancy. METHODS: CSP patients admitted to Shengjing Hospital of China Medical University from January 2013 to December 2018 were retrospectively analyzed to coll...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380377/ https://www.ncbi.nlm.nih.gov/pubmed/35974321 http://dx.doi.org/10.1186/s12884-022-04965-9 |
_version_ | 1784768873682173952 |
---|---|
author | Xu, Zongxu Sheng, Chengcheng Yang, Qing Wang, Jun |
author_facet | Xu, Zongxu Sheng, Chengcheng Yang, Qing Wang, Jun |
author_sort | Xu, Zongxu |
collection | PubMed |
description | PURPOSE: To investigate the surgical treatment approaches for patients with Cesarean scar pregnancy (CSP) and the effects on subsequent pregnancy. METHODS: CSP patients admitted to Shengjing Hospital of China Medical University from January 2013 to December 2018 were retrospectively analyzed to collect their clinical characteristics, and follow-up of postoperative pregnancies. RESULTS: A total of 1126 CSP patients were enrolled in this study, including 595 (52.84%) CSP type I, 415 (36.86%) CSP type II, and 116 (10.30%) CSP type III cases. There were significant differences between the three types of patients in terms of β-HCG levels, gestational sac diameter, clinical symptoms and presence of fetal heartbeat at diagnosis (P < 0.01). Among these, 89.90% of CSP type I, 88.90% of CSP type II and 50% of CSP type III patients were treated with hysteroscopic lesion excision, 7.9% of CSP type I and 2.2% of CSP type II patients underwent ultrasound-monitored curettage, and the remaining patients underwent lesion excision and and simultaneous repair of excised lesions by different routes (trans-laparoscopic, transabdominal or transvaginal methods). And 5.55% of CSP type I, 22.65% of CSP type II and 43.10% of CSP type III patients were treated with adjunctive uterine artery embolization (UAE). The patients were followed up for more than 2 years after surgery. Among the 166 re-pregnancies, 58 (34.94%) were normal pregnancies, 17 patients reoccurred with CSP, the recurrent rate of CSP was 10.24%. All 58 normal pregnancies were terminated by cesarean section, with a mean gestational week of delivery of (38.36 ± 2.25) weeks, a mean birth weight of (3228.45 ± 301.96)g, and the postnatal Apgar score was (9.86 ± 0.23) points at 1 min and all 5 min were 10 points. Logistic regression analysis suggested that the number of previous cesarean deliveries was a risk factor for recurrent CSP (RCSP) (OR = 10.82, 95% CI: 2.52–46.50, P = 0.001). CONCLUSIONS: The type of CSP is related to β-HCG values, presence of fetal heartbeat, gestational sac diameter and clinical symptoms. Hysteroscopic therapy is a commonly used surgical procedure and UAE is often used as an adjuvant treatment. For subsequent pregnancies, the number of previous cesarean deliveries is a risk factor for recurrent CSP. |
format | Online Article Text |
id | pubmed-9380377 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-93803772022-08-17 Analysis of pregnancy outcomes following surgical treatment of cesarean scar pregnancy Xu, Zongxu Sheng, Chengcheng Yang, Qing Wang, Jun BMC Pregnancy Childbirth Research PURPOSE: To investigate the surgical treatment approaches for patients with Cesarean scar pregnancy (CSP) and the effects on subsequent pregnancy. METHODS: CSP patients admitted to Shengjing Hospital of China Medical University from January 2013 to December 2018 were retrospectively analyzed to collect their clinical characteristics, and follow-up of postoperative pregnancies. RESULTS: A total of 1126 CSP patients were enrolled in this study, including 595 (52.84%) CSP type I, 415 (36.86%) CSP type II, and 116 (10.30%) CSP type III cases. There were significant differences between the three types of patients in terms of β-HCG levels, gestational sac diameter, clinical symptoms and presence of fetal heartbeat at diagnosis (P < 0.01). Among these, 89.90% of CSP type I, 88.90% of CSP type II and 50% of CSP type III patients were treated with hysteroscopic lesion excision, 7.9% of CSP type I and 2.2% of CSP type II patients underwent ultrasound-monitored curettage, and the remaining patients underwent lesion excision and and simultaneous repair of excised lesions by different routes (trans-laparoscopic, transabdominal or transvaginal methods). And 5.55% of CSP type I, 22.65% of CSP type II and 43.10% of CSP type III patients were treated with adjunctive uterine artery embolization (UAE). The patients were followed up for more than 2 years after surgery. Among the 166 re-pregnancies, 58 (34.94%) were normal pregnancies, 17 patients reoccurred with CSP, the recurrent rate of CSP was 10.24%. All 58 normal pregnancies were terminated by cesarean section, with a mean gestational week of delivery of (38.36 ± 2.25) weeks, a mean birth weight of (3228.45 ± 301.96)g, and the postnatal Apgar score was (9.86 ± 0.23) points at 1 min and all 5 min were 10 points. Logistic regression analysis suggested that the number of previous cesarean deliveries was a risk factor for recurrent CSP (RCSP) (OR = 10.82, 95% CI: 2.52–46.50, P = 0.001). CONCLUSIONS: The type of CSP is related to β-HCG values, presence of fetal heartbeat, gestational sac diameter and clinical symptoms. Hysteroscopic therapy is a commonly used surgical procedure and UAE is often used as an adjuvant treatment. For subsequent pregnancies, the number of previous cesarean deliveries is a risk factor for recurrent CSP. BioMed Central 2022-08-16 /pmc/articles/PMC9380377/ /pubmed/35974321 http://dx.doi.org/10.1186/s12884-022-04965-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Xu, Zongxu Sheng, Chengcheng Yang, Qing Wang, Jun Analysis of pregnancy outcomes following surgical treatment of cesarean scar pregnancy |
title | Analysis of pregnancy outcomes following surgical treatment of cesarean scar pregnancy |
title_full | Analysis of pregnancy outcomes following surgical treatment of cesarean scar pregnancy |
title_fullStr | Analysis of pregnancy outcomes following surgical treatment of cesarean scar pregnancy |
title_full_unstemmed | Analysis of pregnancy outcomes following surgical treatment of cesarean scar pregnancy |
title_short | Analysis of pregnancy outcomes following surgical treatment of cesarean scar pregnancy |
title_sort | analysis of pregnancy outcomes following surgical treatment of cesarean scar pregnancy |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380377/ https://www.ncbi.nlm.nih.gov/pubmed/35974321 http://dx.doi.org/10.1186/s12884-022-04965-9 |
work_keys_str_mv | AT xuzongxu analysisofpregnancyoutcomesfollowingsurgicaltreatmentofcesareanscarpregnancy AT shengchengcheng analysisofpregnancyoutcomesfollowingsurgicaltreatmentofcesareanscarpregnancy AT yangqing analysisofpregnancyoutcomesfollowingsurgicaltreatmentofcesareanscarpregnancy AT wangjun analysisofpregnancyoutcomesfollowingsurgicaltreatmentofcesareanscarpregnancy |